Recent laboratory tests have confirmed ACTIVE 2.0’s revolutionary efficacy fighting killer bacteria such as Serratia Marcescens, which recently caused the death of a newborn baby in an Italian hospital.

The Iris Ceramica Group’s R&D department has been working on the development and monitoring of the technology for a long time, and recently conducted new tests assessing its effect on a real-life case.
The samples, sent to the Artest laboratory in Modena, produced a positive outcome, demonstrating the product’s efficacy against this bacterium too.
This confirmation is of primary importance supporting application of Active Clean Air & Antibacterial Ceramic® materials in hospitals and other healthcare facilities with particularly high standards of cleanliness and sanitation.
This important milestone once more demonstrates the Group’s focus on designing products that make a significant contribution to the wellbeing of individuals and the community.